載入...

The off-label use of targeted therapies in sarcomas: the OUTC’S program

BACKGROUND: Few targeted therapies (TTs) are registered for sarcoma treatment despite numerous phase II studies and yet there are potential treatment options for patients after standard treatment escape. The French Sarcoma Group - Bone Tumor Study Group (GSF-GETO) created a national registry to eval...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Cancer
Main Authors: Eberst, Lauriane, Cropet, Claire, Le Cesne, Axel, Pautier, Patricia, Penel, Nicolas, Adenis, Antoine, Chevreau, Christine, Bay, Jacques-Olivier, Collard, Olivier, Cupissol, Didier, Duffaud, Florence, Gentet, Jean-Claude, Piperno-Neumann, Sophie, Marec-Berard, Perrine, Bompas, Emmanuelle, Thyss, Antoine, Chaigneau, Loic, Cassier, Philippe, Bertucci, François, Blay, Jean-Yves, Ray-Coquard, Isabelle
格式: Artigo
語言:Inglês
出版: BioMed Central 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289372/
https://ncbi.nlm.nih.gov/pubmed/25420707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-870
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!